Associate Professor Ruth Colagiuri, founder of the Juvenile Arthritis Foundation Australia, whose grandchild lives with arthritis, told BioPharmaDispatch that the announcement was excellent news for the community because it an important treatment option affordable for more families. …
'Juvenile arthritis is one of the most under-recognised, misunderstood, and neglected childhood
December 11, 2023 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Australians want more from healthcare as convenience, prevention and fragmentation reshape care
June 18, 2026 - - Latest News -
Life sciences leaders brace for class action wave as dispute risks multiply
June 18, 2026 - - Latest News -
Is China's international benchmarking a bigger short-term risk to medicines access?
June 18, 2026 - - Latest News -
Neurizon secures GMP supply of monepantel to strengthen NUZ 001 commercial readiness
June 17, 2026 - - Australian Biotech -
Percheron completes HMBD-002 drug substance manufacture
June 17, 2026 - - Australian Biotech -
Racura completes significant fund raise to advance three clinical trials
June 17, 2026 - - Australian Biotech -
Novartis names interim leader for Australia and NZ after Country President departs
June 17, 2026 - - Latest News